CD4 and tropical spastic paraparesis: In the context of HTLV-1 infection, these polymorphisms could influence the clinical evolution of the disease by modulating the efficacy in the virus elimination, the level of chronic inflammation, and the immune control over the infected CD4+ cells, which are considered important aspects in the progression from the asymptomatic carrier state to severe conditions such as ATL or HAM/TSP [17].